GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Certuity LLC

Certuity LLC reduced its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 98.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 3,734 shares of the company's stock after selling 201,079 shares during the period. Certuity LLC's holdings in GE HealthCare Technologies were worth $289,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Van ECK Associates Corp purchased a new stake in GE HealthCare Technologies during the 4th quarter worth approximately $4,475,000. Skylands Capital LLC increased its position in shares of GE HealthCare Technologies by 22.7% in the 4th quarter. Skylands Capital LLC now owns 112,050 shares of the company's stock valued at $8,664,000 after acquiring an additional 20,725 shares during the period. Choreo LLC raised its stake in GE HealthCare Technologies by 11.8% in the 4th quarter. Choreo LLC now owns 3,647 shares of the company's stock worth $282,000 after acquiring an additional 384 shares during the last quarter. Sector Gamma AS lifted its position in GE HealthCare Technologies by 7.8% during the 4th quarter. Sector Gamma AS now owns 247,531 shares of the company's stock worth $19,139,000 after acquiring an additional 17,942 shares during the period. Finally, Schwarz Dygos Wheeler Investment Advisors LLC grew its stake in GE HealthCare Technologies by 5.9% during the 4th quarter. Schwarz Dygos Wheeler Investment Advisors LLC now owns 4,109 shares of the company's stock valued at $318,000 after purchasing an additional 228 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, insider Frank R. Jimenez purchased 1,315 shares of the firm's stock in a transaction on Wednesday, May 1st. The stock was bought at an average cost of $76.52 per share, with a total value of $100,623.80. Following the acquisition, the insider now directly owns 75,796 shares of the company's stock, valued at $5,799,909.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.27% of the company's stock.

Analyst Ratings Changes

Several research analysts recently issued reports on GEHC shares. Citigroup raised their target price on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a "buy" rating in a report on Wednesday, April 3rd. UBS Group upgraded GE HealthCare Technologies from a "sell" rating to a "neutral" rating and upped their target price for the stock from $66.00 to $88.00 in a research note on Monday, February 12th. Mizuho reduced their price target on GE HealthCare Technologies from $110.00 to $105.00 and set a "buy" rating for the company in a research report on Wednesday. HSBC assumed coverage on GE HealthCare Technologies in a research report on Thursday, February 15th. They set a "buy" rating and a $100.00 price target on the stock. Finally, Evercore ISI boosted their target price on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an "outperform" rating in a research note on Thursday, April 4th. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of "Moderate Buy" and a consensus price target of $95.00.

GE HealthCare Technologies Price Performance

NASDAQ GEHC traded down $0.43 during trading hours on Thursday, hitting $77.83. 2,995,442 shares of the company's stock traded hands, compared to its average volume of 3,461,109. The company has a market capitalization of $35.52 billion, a PE ratio of 22.76, a PEG ratio of 2.65 and a beta of 1.26. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.06 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.50. The firm's 50-day moving average is $88.64 and its 200-day moving average is $78.81.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, hitting the consensus estimate of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The company had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.80 billion. During the same period in the prior year, the business posted $0.85 earnings per share. The firm's revenue for the quarter was down 1.2% compared to the same quarter last year. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a dividend of $0.03 per share. The ex-dividend date is Thursday, April 18th. This represents a $0.12 annualized dividend and a yield of 0.15%. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.51%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.